The National Institutes of Health requires an Institutional Biosafety Committee for any organization that receives federal funding to perform work with recombinant or synthetic nucleic molecules. The committee must approve all work with the following materials, and provide oversight to biosafety related research at Rutgers University. The Institutional Biosafety Committee reviews and approves all research at Rutgers University that falls into the following categories:
- Recombinant and synthetic nucleic acids
- Pathogenic Microorganisms (bacteria, viruses, parasites, fungi, etc. at BSL2 and higher)
- Biological Toxins
- Creation of a transgenic animal
- Creation of a transgenic plant
- Administration of rDNA to an animal or plant
- Human Gene Therapy
- Research with Human cells or human materials
- Dual Use Research of Concern
The protocol form for the IBC is online at myrehs.rutgers.edu in the Biosafety Protocol Management System (BPMS).
For access to the BPMS, or for assistance with the IBC protocol form, please contact biosafety@rutgers.edu
- Rutgers Guidelines for COVID-19 Research
All researchers must receive IBC approval prior to beginning work with any COVID-19 related materials. The IBC has approved a SARS-CoV-2 Laboratory Research Guidelines, which define relevant biosafety levels, containment requirements, inactivation information, and points of contact for working with COVID-19 related research materials. For any questions about IBC requirements for COVID-19 related research, please email biosafety@rutgers.edu.
- IBC Co-Chairs
Ronald Hart, Ph.D.
Professor, Department of Cell Biology and Neuroscience
Division of Life Sciences and Center for Collaborative Neuroscience
Chair, Central Standing Committee
rhart@rutgers.edu
Sergei Kotenko, Ph.D.
Professor, Department of Microbiology, Biochemistry and Molecular Genetics
Chair, North Standing Committee
kotenkse@njms.rutgers.edu
The committee roster has been approved by the NIH Office of Science Policy and meets the requirements for the IBC composition as outlined in the NIH Guidelines.- IBC Handbook
- Accessing IBC Protocols & Approval Letters
If you are a Rutgers PI and need a copy of your IBC approval letter for a grant application or award, you can find it in the File Cabinet section of your protocol. Log into the Biosafety Protocols database via MyREHS (myrehs.rutgers.edu), select 'View' to open your protocol, click the “File Cabinet” button, and look for the latest version under “System Files”. You can also find a printable PDF copy of your approved protocol in this same section (choose the latest version number).
- Meeting Dates & Submission Deadlines
Rutgers University maintains two standing Institutional Biosafety Committees, North and Central Committees, which share responsibility for reviewing IBC protocols submitted across the university, regardless of campus affiliation. These committees alternate meeting monthly, with special meetings convened as needed. IBC meetings are held virtually and are only open to members of the IBC, REHS Biosafety staff, and individuals who have received prior approval from an IBC chair to attend.
Note: To be eligible for inclusion on a meeting agenda, protocols must be submitted before the monthly Submission Deadline (see schedule below).Year Month Meeting Day Submission Deadline 2025 December Wednesday, December 3 Wednesday, November 19 2026 January Tuesday, January 13 Tuesday, December 19 2026 February Wednesday, February 4 Wednesday, January 14 2026 March Tuesday, March 10 Tuesday, February 17 2026 April Wednesday, April 1 Wednesday, March 11 2026 May Tuesday, May 12 Tuesday, April 21 2026 June Wednesday, June 3 Wednesday, May 13 2026 July Tuesday, July 14 Tuesday, June 23 2026 August Wednesday, August 5 Wednesday, July 15 2026 September Tueday, September 8 Tueday, August 18 2026 October Wednesday, October 7 Wednesday, September 16 2026 November Tueday, November 10 Tueday, October 20 2026 December Wednesday, December 2 Wednesday, November 11 - IBC Meeting Minutes
Rutgers University maintains two standing Institutional Biosafety Committees, North and Central Committees, which share responsibility for reviewing IBC protocols submitted across the university, regardless of campus affiliation. These committees alternate meeting monthly and typically meeting minutes are formally approved at the subsequent meeting of the committee to which they pertain. Once approved, minutes are posted and made available in accordance with the NIH Guidelines and under New Jersey public access regulations and institutional policies.IBC Meeting Minutes
2025 Meetings June 4 July 8 August 6 September 9 October 1 November 11 December 3